SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Zonagen (zona) - good buy?

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: VLAD who wrote (6590)5/10/1999 4:50:00 PM
From: Cacaito  Read Replies (2) of 7041
 
Zona's cash $40 M? No debt. Joe P is smart. He won't care stock price.

Either they will compensate the executives nicely till the money is gone.

Or they could shop around for small biotechs cash starve, for licensing or outright buyouts.

Farfetched? Not so, Joe P got to this point doing just that, He never dream to hit so good with Phantolamine.

Zona the stock is going to $1, even with the $3 per share as cash in hand.

But the company could survive if they have half a brain. Too much cheap biotechs around. JoeP go an buyout NTII, they need cash. If you are not too greedy you could have real drugs in your pipeline.

I will not be surprise if it becomes E-zona.net.com or something like that. JoeP go, only you could turn a biotech into an internut.

JoeP you survive the first lawsuits and Asensio's first round, You could go ahead and survive the 2nd coming.

Joe P could even try merging with Vivus. He has more brains and more cool than Vivus entire board.


Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext